Global Opioid-Induced Constipation Market to Grow at a CAGR of 30.18% over the Period 2015-2019

The Report Global Opioid-Induced Constipation Market 2015-2019 provides information on pricing, market analysis, shares, forecast, and company profiles for key industry participants. -


Albany, NY -- (SBWIRE) -- 07/09/2015 -- About Opioid-induced Constipation

Opioids are administered to the patients with acute and non-cancer chronic pain. They have several adverse gastrointestinal effects, one of which is opioid-induced constipation. The opioid analgesics produce analgesia by the activation of the mu receptors found in the CNS and PNS. These drugs affect the motility, tone, and contractility of the bowel functions, which results in the delay in the transit of fecal contents. The opioids also cause a reduction in the secretion of digestive enzymes and also cause partial gastroparesis. Some of the common symptoms of opioid-induced constipation are hard and dry stools, painful defecation, bloating, distention and bulged abdomen, feeling lethargic, and loss of appetite. Opioid-induced constipation can be managed by changing lifestyle along with the use of targeted therapies and other OTC and off-label drugs.

View Full Report at

Technavio's analysts forecast the global opioid-induced constipation market to grow at a CAGR of 30.18% over the period 2014-2019.

Covered in this Report

This report covers the present scenario and the growth prospects of the global opioid-induced constipation market for 2015-2019. To calculate the market size, the report considers revenue generated from sales of various drugs used in the treatment of opioid-induced constipation, which includes branded drugs, off-label products, and OTC drugs.

On the basis of the mechanism of action of drugs, the market is grouped into the following categories:

Peripherally Acting Mu-opioid Receptor Antagonist
Locally Acting Chloride Channel Activator

Download Sample Copy of this Report at

On the basis of the route of administration of drugs, the market is grouped into the following categories:


On the basis of the dosage form of drugs, the market is grouped into the following categories:


Technavio's report, Global Opioid-induced Constipation Market 2015-2019, has been prepared based on an in-depth market analysis with inputs from industry experts. The report covers the market landscape and its growth prospects in the coming years. The report also includes a discussion of the key vendors operating in this market.

Key Regions

Key Vendors
Takeda Pharmaceutical
Valeant Pharmaceuticals International
Other Prominent Vendors

Boehringer Ingelheim
C.B. Fleet
Cosmo Pharmaceuticals
Daiichi Sankyo
Ironwood Pharmaceuticals
Johnson & Johnson
Nektar Therapeutics
Progenics Pharmaceuticals
SLA Pharma
Synergy Pharmaceuticals

Market Driver

Unmet Medical Needs
For a full, detailed list, view our report

Market Challenge

Availability of OTC and Off-label Drugs
For a full, detailed list, view our report

Market Trend

Shift to Targeted Therapy
For a full, detailed list, view our report

Key Questions Answered in this Report

What will the market size be in 2019 and what will the growth rate be?
What are the key market trends?
What is driving this market?
What are the challenges to market growth?
Who are the key vendors in this market space?
What are the market opportunities and threats faced by the key vendors?
What are the strengths and weaknesses of the key vendors?

About is the most comprehensive collection of market research reports. MarketResearchReports.Biz services are specially designed to save time and money for our clients. We are a one stop solution for all your research needs, our main offerings are syndicated research reports, custom research, subscription access and consulting services. We serve all sizes and types of companies spanning across various industries.

Read our latest articles at

Contact US:
90 Sate Street, Suite 700
Albany, NY 12207
Tel: 518-618-1030
USA: Canada Toll Free: 866-997-4948